Condition (MeSH)
Chorioretinitis
ClinicalTrials.gov lists 14 trials for Chorioretinitis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
9 of the 14 trials are tagged with Chorioretinitis itself; the rest are tagged with a narrower condition beneath it.
When did Chorioretinitis trials start? (12)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 3
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2023 | 2 |
| 2022 | 1 |
| 2020 | 1 |
| 2018 | 1 |
| 2013 | 1 |
| 2011 | 1 |
| 2010 | 2 |
| 2008 | 1 |
| 2007 | 1 |
Showing 10 of 12 earlier years.
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 14 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Chorioretinitis trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 2 |
| Not applicable | 2 |
| Observational | 8 |
How many Chorioretinitis trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Completed | 7 |
| Withdrawn | 1 |
| Unknown status | 4 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Chorioretinitis trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Novartis Pharmaceuticals | 1 |
| TScan Therapeutics, Inc. | 1 |
Which drugs are being tested for Chorioretinitis? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Interferon Alfa 2A | 1 |
| Prednisone | 1 |
Interventions as named in the registry (10)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| pyrimethamine-sulfadiazine + prednisolone | 1 |
| Anti-toxoplasmosis treatment | 1 |
| Secukinmab | 1 |
| Fluconazol | 1 |
| Observational Study | 1 |
Showing 5 of 10 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Chorioretinitis trials report? (5)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Hypokalaemia | 1 | 1 |
| Pyelonephritis | 1 | 1 |
| Tibia fracture | 1 | 1 |
| Urinary tract infection | 1 | 1 |
| Uterine cancer | 1 | 1 |
Which publications cover Chorioretinitis? (21)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Quality of Life in Patients with Birdshot Chorioretinitis Aged 80 and Older. | Ocular immunology and inflammation | 2025 | Yes |
| Peripapillary atrophy in patients with birdshot chorioretinitis. | The British journal of ophthalmology | 2025 | Yes |
| Choroidal Imaging with Swept-Source Optical Coherence Tomography in Patients with Birdshot Chorioretinopathy: Choroidal Reflectivity and Thickness. | Ophthalmology | 2017 | Yes |
| Birdshot Chorioretinopathy. | Ocular immunology and inflammation | 2017 | Yes |
| Characterization of punctate inner choroidopathy using enhanced depth imaging optical coherence tomography. | Ophthalmology | 2014 | Yes |
Showing 5 of 21 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.